Fintech PR
Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2022 Global Pitch Competition Launches
Alibaba Hong Kong Entrepreneurs Fund (“AEF”) today announced that HSBC will be the title sponsor of the startup event JUMPSTARTER, which will be named Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2022 Global Pitch Competition (“JUMPSTARTER 2022”). AEF and HSBC will be working closely together to promote the event to startups worldwide, and encourage interaction and experience sharing among entrepreneurs.
JUMPSTARTER 2022 is now open for applications until November 28, 2021. The top 100 entrants will be selected by the judging panel and enter the pitching phase in December. The top 10 will participate in the finals early next year, competing for a total of up to USD4 million investment* and other various awards. Hong Kong Cyberport Management Company Limited (“Cyberport”) and Hong Kong Science and Technology Parks Corporation (“HKSTP”), co-organizers of the event, will take part in a joint investment to provide further support to fuel the growth of startups.
The top 10 finalists of JUMPSTARTER 2022 will have the opportunities to participate in exchange programs and/or market research activities managed by AEF in Hong Kong and other cities in the Greater Bay Area (“GBA”). In addition, JUMPSTARTER 2022 will arrange industry experts to share their experience, helping startups to understand more about the market environment in the GBA and expand their business network, so as to identify opportunities for future growth.
Meanwhile, the top 100 of JUMPSTARTER 2022 will take part in the Alibaba Netpreneur Training Program. The quota is increased from the top 20 last year to the top 100 this year, as a way to provide network and resource support, apart from capital, for the startups.
Cindy Chow, Executive Director of Alibaba Hong Kong Entrepreneurs Fund, said, “Since onset of the pandemic, like other startups, Alibaba Hong Kong Entrepreneurs Fund has never slowed down its pace and continued to respond to market change in a swift and active manner. Noticing the rapid development of the startup ecosystem and market, JUMPSTARTER 2022 caters to the current trend and focuses on five sectors including Fintech, Deep Tech, Healthcare, Art Tech and Sustainability. It hopes to act as a bridge to connect the startups, facilitating them to learn more about the latest trends in the market. AEF believes that JUMPSTARTER 2022 can encourage and support the startups to further develop, injecting new impetus into Hong Kong and other cities in the GBA.”
Christina Ong, Head of Business Banking, Commercial Banking, Hong Kong, HSBC, said: “HSBC is committed to supporting start-ups and small businesses across all sectors along their growth journey. As an up-and-coming economic powerhouse, the Greater Bay Area offers the combined strengths of an international capital market for fundraising, research capabilities, manufacturing facilities and an enormous consumer market for start-ups to grow and thrive. JUMPSTARTER 2022 offers an excellent platform for entrepreneurial talents to capture the ample market opportunities in this vibrant city cluster, and unleash their potential over time.”
Peter Yan, Chief Executive Officer, Cyberport, said: “Complementing the National 14th Five-Year Plan, Hong Kong is deepening and expanding its connection with the GBA to allow more room to develop technology and innovation. As the digital technology flagship of Hong Kong, Cyberport has been actively supporting startups to expand their business and tap into the GBA. We encourage more startups to seize the opportunity and compete for the support offered by JUMPSTARTER 2022. With an increasing number of startup projects supported by capital from Mainland China and successful landings in the GBA, we believe we can achieve greater synergy to facilitate the development of the GBA as an international technology and innovation hub.”
Albert Wong, Chief Executive Officer, HKSTP, said: “HKSTP has always been dedicated to building a vibrant and competitive I&T ecosystem in Hong Kong and GBA by helping startups scale and access a host of resources including industry expertise, partner and investor networks, and R&D support. We are delighted to continue our partnership with Alibaba Hong Kong Entrepreneurs Fund to support promising startups and inspire more young talent to begin their entrepreneurial journey through JUMPSTARTER 2022. Together, we will capture new opportunities emerging from GBA to accelerate the development of I&T for a brighter future.”
JUMPSTARTER 2022 is open to startups that have been operating for less than five years and plan to expand into Hong Kong or other cities in the GBA (see below appendix for more requirements).
Another highlight this year is the four online sharing sessions in early November that will target startups from cities in Mainland China, Guangdong-Hong Kong-Macao Greater Bay Area and Southeast Asia. Successful startups and experts from a variety of industries will be invited to share their experiences during their entrepreneurial period, such as how to solve problems, the reasons for choosing Hong Kong or other cities in the GBA to develop business, analyze the business environment in the region, and the development opportunities of multiple emerging industries.
“Developments in the GBA offer unlimited opportunities, the economic scale is comparable to that of metropolitan areas such as New York, San Francisco and Tokyo, bringing huge development potential for startups. We have noticed the rising demand from startups to explore business and financing opportunities in the GBA. With the help of our partners, we hope to deliver more abundant online and offline resources and sharing activities, which support them to further explore the business environment for startups in these cities. Looking forward, AEF will continue to focus on achieving goals for participants, and encourage more institutions with the same vision to join us in nurturing startups,” Chow added.
Since its establishment, Alibaba Hong Kong Entrepreneurs Fund has invested approximately USD80 million into 55 startups^, attracting co-investment funding of about USD2 billion to support these startups. Its investment portfolio covers a wide range of areas, including green technology, educational technology, fintech, medical and healthcare, logistics and e-commerce.
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News5 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News5 days ago
Banxso Acquires Australian ASIC License, Enhancing Its Global Trading Operations
-
Latest News4 days ago
BMO Announces Election of Board of Directors
-
Latest News5 days ago
135th Canton Fair Launches a Showcase of Innovative Products of New Collection to Lead Global Market Trends
-
Latest News4 days ago
HaloWallet Rebrands To Halo: Integrating SocialFi & AI To Revolutionize Social Influence Monetization
-
Latest News6 days ago
BII and FMO back BECIS with joint US$50 million financing facility supporting commercial and industrial renewables sector in South-East Asia
-
Fintech1 day agoHow to identify authenticity in crypto influencer channels